Download India's most affordable pharmacy app
- Compare with medicine prices
- Save upto 90% on your medicine bills
COMPOSITION:
Linagliptin (5 mg)DESCRIPTION:
Introduction
Juslina 5mg Tablet is a medication primarily used for managing and treating hormonal imbalances and conditions related to menopause. It contains the active ingredient Estradiol, a form of estrogen.
Uses
- Hormone replacement therapy (HRT) for menopausal symptoms such as hot flashes and vaginal dryness.
- Treatment of estrogen deficiency in conditions like osteoporosis and post-menopausal women.
- Management of other estrogen-related disorders.
How it Works
Juslina 5mg Tablet works by supplementing the body's natural estrogen levels, which helps relieve symptoms associated with menopause and other estrogen-related deficiencies.
Benefits
- Reduces menopausal symptoms such as hot flashes and night sweats.
- Improves bone density and reduces the risk of osteoporosis.
- Helps in maintaining skin elasticity and preventing vaginal atrophy.
How to Take
- Take Juslina 5mg Tablet as prescribed by your healthcare provider.
- Usually taken once daily with or without food.
- Swallow the tablet whole with a glass of water.
Side Effects
- Nausea
- Headache
- Breast tenderness
- Weight changes
Safety Advice
- Inform your doctor about any pre-existing conditions or allergies.
- Avoid smoking while on Juslina 5mg as it increases the risk of cardiovascular issues.
- Do not stop taking Juslina abruptly without consulting your doctor.
Frequently Asked Questions
Q: Can Juslina 5mg be used during pregnancy?
A: No, Juslina is not recommended during pregnancy. Consult your doctor for appropriate alternatives.
Q: Are there any long-term risks associated with Juslina 5mg?
A: Long-term use may increase the risk of certain conditions like breast cancer or cardiovascular issues; regular medical check-ups are advised.
© 2025 Copyright By Zeelab Pharmacy Private Limited. All Rights Reserved
Terms and conditions|
Cancellation Policy|
Privacy Policy|
App Privacy Policy|
Return Policy|
Government Licence

